Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1

Blood Cancer J. 2019 Oct 2;9(10):82. doi: 10.1038/s41408-019-0242-4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antioxidants / therapeutic use*
  • Ascorbic Acid / therapeutic use*
  • DNA-Binding Proteins / genetics*
  • Dioxygenases
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Proto-Oncogene Proteins / genetics*
  • Remission Induction
  • Treatment Outcome
  • WT1 Proteins / genetics*

Substances

  • Antioxidants
  • DNA-Binding Proteins
  • Proto-Oncogene Proteins
  • WT1 Proteins
  • WT1 protein, human
  • Dioxygenases
  • TET2 protein, human
  • Ascorbic Acid